Background Background Obsessions and compul-
Obsessions and compulsions may occur in the post-streptococcal sions may occur in the post-streptococcal disorders Sydenham's chorea and paediadisorders Sydenham's chorea and paediatric autoimmune neuropsychiatric tric autoimmune neuropsychiatric disorders associated with streptococcus disorders associated with streptococcus (PANDAS).The proposed mediators are (PANDAS).The proposed mediators are anti-basalganglia antibodies (ABGA). anti-basalganglia antibodies (ABGA).
Aims Aims We tested the hypothesis that
We tested the hypothesis that post-streptococcal autoimmunity may post-streptococcal autoimmunity may have a role in'idiopathic'obsessiveĥave a role in'idiopathic'obsessiveĉ ompulsive disorder (OCD). compulsive disorder (OCD).
Method Method We examined 50 children
We examined 50 children with OCD for ABGA using enzyme-linked with OCD for ABGA using enzyme-linked immunosorbent assay (ELISA) and immunosorbent assay (ELISA) and western immunoblotting.The findings western immunoblotting.The findings were compared with paediatric autowere compared with paediatric autoimmune ( immune (n n¼50), neurological ( 50), neurological (n n¼100) 100) and streptococcal ( and streptococcal (n n¼40) controls. 40) controls.
Results

The mean ABGA binding on The mean ABGA binding on ELISAwas elevated in the patient cohort ELISAwas elevated in the patient cohort compared with all control groups compared with all control groups ( (P P5 50.005 in all comparisons).Western 0.005 in all comparisons).Western immunoblotting revealed positive antiimmunoblotting revealed positive antibody binding (as seen in Sydenham's body binding (as seen in Sydenham's chorea) in 42% of the patient cohort chorea) in 42% of the patient cohort compared with 2^10% of control groups compared with 2^10% of control groups ( (P P5 50.001in all comparisons). 0.001in all comparisons).
Conclusions
Conclusions Our findings supportthe Our findings supportthe hypothesis that central nervous system hypothesis that central nervous system autoimmunity may have a role in a autoimmunity may have a role in a significant subgroup of cases of OCD. significant subgroup of cases of OCD. Further study is required to examine Further study is required to examine whether the antibodies concerned are whether the antibodies concerned are pathogenic. pathogenic.
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Obsessions and compulsions commonly Obsessions and compulsions commonly occur in the post-streptococcal movement occur in the post-streptococcal movement disorders Sydenham's chorea and paediadisorders Sydenham's chorea and paediatric autoimmune neuropsychiatric disorders tric autoimmune neuropsychiatric disorders associated with streptococcal infections associated with streptococcal infections (Swedo (Swedo et al et al, 1998; Mercadante , 1998; Mercadante et al et al, , 2000) . These disorders are thought to be 2000). These disorders are thought to be autoimmune in origin, in that antibodies autoimmune in origin, in that antibodies raised in response to streptococcus crossraised in response to streptococcus crossreact with the basal ganglia. We have react with the basal ganglia. We have recently described serum anti-brain antirecently described serum anti-brain antibodies that bind to basal ganglia proteins bodies that bind to basal ganglia proteins in patients with post-streptococcal brain in patients with post-streptococcal brain syndromes (Church syndromes (Church et al et al, 2002 (Church et al et al, , 2003 (Church et al et al, , 2002 (Church et al et al, , 2003a ; Dale Dale et al et al, 2004) . The recognition that , 2004). The recognition that obsessions and compulsions may occur obsessions and compulsions may occur after streptococcal infection has led to the after streptococcal infection has led to the hypothesis that a subgroup of obsessivehypothesis that a subgroup of obsessivecompulsive disorder might be secondary compulsive disorder might be secondary to post-streptococcal autoimmunity. We to post-streptococcal autoimmunity. We tested this hypothesis by measuring antitested this hypothesis by measuring antibasal ganglia antibodies in a cohort of basal ganglia antibodies in a cohort of unselected individuals with obsessiveunselected individuals with obsessivecompulsive disorder, and comparing the compulsive disorder, and comparing the findings with paediatric control groups. findings with paediatric control groups.
METHOD METHOD Patients Patients
Fifty children and adolescents with Fifty children and adolescents with obsessive-compulsive disorder were obsessive-compulsive disorder were recruited from a specialist clinic between recruited from a specialist clinic between August 2001 and August 2002. Ethics August 2001 and August 2002. Ethics approval was granted by the local comapproval was granted by the local committee. Consecutive patients were screened mittee. Consecutive patients were screened for probable obsessive-compulsive disorder for probable obsessive-compulsive disorder before attending the clinic, and all underbefore attending the clinic, and all underwent a detailed clinical assessment by child went a detailed clinical assessment by child psychiatrists and psychologists. All those psychiatrists and psychologists. All those meeting DSM-IV criteria for the disorder meeting DSM-IV criteria for the disorder (American Psychiatric Association, 1994) (American Psychiatric Association, 1994) were invited to participate in the study. were invited to participate in the study. All patients were assessed with a structured All patients were assessed with a structured diagnostic interview, the Children's Yalediagnostic interview, the Children's YaleBrown Obsessive Compulsive Scale (CYBrown Obsessive Compulsive Scale (CY-BOCS; Scahill BOCS; Scahill et al et al, 1997) , at the time of , 1997), at the time of serological examination (mean score 19.5, serological examination (mean score 19.5, range 5-33). The symptom characteristics range 5-33). The symptom characteristics of the total cohort are presented in Table  of the total cohort are presented in Table  1 , including medication status (56% of 1, including medication status (56% of the sample). Patients were taking paroxethe sample). Patients were taking paroxetine ( tine (n n¼9), fluoxetine ( 9), fluoxetine (n n¼7), sertraline 7), sertraline ( (n n¼9) or clomipramine ( 9) or clomipramine (n n¼3) at the time 3) at the time of sampling. The mean age at symptom onof sampling. The mean age at symptom onset (retrospectively) was 8.9 years and the set (retrospectively) was 8.9 years and the mean age at the time of assessment was mean age at the time of assessment was 13.0 years (range 6-16). After complete 13.0 years (range 6-16). After complete description of the study to the participants, description of the study to the participants, written informed consent was obtained written informed consent was obtained from the family. from the family.
Controls Controls
For comparison in the serological study, we For comparison in the serological study, we recruited paediatric control groups: a recruited paediatric control groups: a neurological control group with stroke, neurological control group with stroke, metabolic movement disorders and encemetabolic movement disorders and encephalitis ( phalitis (n n¼100, mean age 8.2 years, range 100, mean age 8.2 years, range 1-16 years, 50 males); a group with 1-16 years, 50 males); a group with uncomplicated streptococcal infections, uncomplicated streptococcal infections, defined as laboratory-confirmed streptodefined as laboratory-confirmed streptococcal pharyngitis without autoimmune or coccal pharyngitis without autoimmune or invasive complications ( invasive complications (n n¼40, mean age 40, mean age 9.8 years, range 2-15 years, 25 males); 9.8 years, range 2-15 years, 25 males); and a third group of children with autoand a third group of children with autoimmune disorders without neurological immune disorders without neurological involvement, including rheumatic carditis involvement, including rheumatic carditis and post-streptococcal glomerulonephritis and post-streptococcal glomerulonephritis ( (n n¼50, mean age 9.2 years, range 2-16 50, mean age 9.2 years, range 2-16 years, 25 males). Some of these control years, 25 males). Some of these control groups had been previously reported groups had been previously reported (Church (Church et al et al, 2003 (Church et al et al, , 2003b . The control groups ). The control groups were recruited during the same period as were recruited during the same period as the obsessive-compulsive disorder cohort the obsessive-compulsive disorder cohort 
Serology Serology
All serum samples were coded and stored at All serum samples were coded and stored at 7 780 80 8 8C prior to streptococcal serological C prior to streptococcal serological investigation, in which anti-streptolysin O investigation, in which anti-streptolysin O titres were measured using the Dade titres were measured using the Dade Behring BN II nephelometer (http:// Behring BN II nephelometer (http:// www.dadebehring.com). All control group www.dadebehring.com). All control group levels were within acceptable parameters. levels were within acceptable parameters. Titres greater than 200 IU/ml were conTitres greater than 200 IU/ml were considered significant according to World sidered significant according to World Health Organization guidelines (Spaun Health Organization guidelines (Spaun et al et al, 1961) . Streptococcal serological , 1961) . Streptococcal serological measurements took place in a different measurements took place in a different laboratory from the other tests, with inveslaboratory from the other tests, with investigators masked to the anti-basal ganglia tigators masked to the anti-basal ganglia antibody results. antibody results.
The methods for assaying anti-basal The methods for assaying anti-basal ganglia antibodies have been described by ganglia antibodies have been described by Church Church et al et al (2002) . All participants in (2002) . All participants in the patient and control groups had their the patient and control groups had their antibody levels measured using both antibody levels measured using both 314 314 gives a semi-quantitative measurement of antibody binding to measurement of antibody binding to antigens, whereas western blotting can antigens, whereas western blotting can define specific antibody-antigen interdefine specific antibody-antigen interactions. For both assays, the antigen was actions. For both assays, the antigen was homogenised delipidated human basal homogenised delipidated human basal ganglia (caudate and putamen). Human ganglia (caudate and putamen). Human immunoglobulin G (IgG) was first removed immunoglobulin G (IgG) was first removed from the homogenised antigen using from the homogenised antigen using Protein A. Samples from patients and Protein A. Samples from patients and controls were coded and assayed at the controls were coded and assayed at the same time on the same ELISA plates and same time on the same ELISA plates and western blots. A 96-well ELISA plate was western blots. A 96-well ELISA plate was incubated with basal ganglia homogenate incubated with basal ganglia homogenate overnight. The plate was then blocked with overnight. The plate was then blocked with 2% bovine specific albumin, and washed 2% bovine specific albumin, and washed with normal saline (0.9% sodium chloride) with normal saline (0.9% sodium chloride) with 0.2% milk proteins and 0.025% with 0.2% milk proteins and 0.025% Tween. Duplicate serum samples were diTween. Duplicate serum samples were diluted 1:300 and incubated for 1 h. After luted 1:300 and incubated for 1 h. After washing, 1:1000 rabbit anti-human IgG washing, 1:1000 rabbit anti-human IgG conjugated with horseradish peroxidase conjugated with horseradish peroxidase (Dako, Glostrup, Denmark) was incubated (Dako, Glostrup, Denmark) was incubated for a further hour. After washing, the for a further hour. After washing, the plate was developed with the reagent plate was developed with the reagent o o-phenylenediamine for 15 min and -phenylenediamine for 15 min and stopped with 1 mol/l hydrochloric acid. A stopped with 1 mol/l hydrochloric acid. A known positive and negative control was known positive and negative control was used on all ELISA plates. For western blotused on all ELISA plates. For western blotting, the basal ganglia homogenate was ting, the basal ganglia homogenate was mixed with lithium dodecyl sulphate and mixed with lithium dodecyl sulphate and 0.05 mol/l dithiothreitol and heated at 0.05 mol/l dithiothreitol and heated at 65 65 8 8C for 15 min; 30 C for 15 min; 30 m mg of protein was g of protein was loaded onto a 4-12% Bis-Tris gel and subloaded onto a 4-12% Bis-Tris gel and subjected to electrophoresis. The gel was transjected to electrophoresis. The gel was transferred to nitrocellulose (BioRad, Hemel ferred to nitrocellulose (BioRad, Hemel Hempstead, UK) and the proteins blocked Hempstead, UK) and the proteins blocked with 2% milk proteins. The blot was with 2% milk proteins. The blot was loaded onto a manifold and serum samples loaded onto a manifold and serum samples diluted 1:300 were incubated overnight. diluted 1:300 were incubated overnight. Samples were washed with normal saline Samples were washed with normal saline with 0.2% milk proteins and 0.025% with 0.2% milk proteins and 0.025% Tween. The secondary antibody (rabbit Tween. The secondary antibody (rabbit anti-human IgG conjugated with horseanti-human IgG conjugated with horseradish peroxidase) was diluted 1:1000 and radish peroxidase) was diluted 1:1000 and incubated for 2 h. The blot was then incubated for 2 h. The blot was then washed again and developed with substrate washed again and developed with substrate 4-chloro-1-naphthol for 15 min. A positive 4-chloro-1-naphthol for 15 min. A positive western blot result was reported when there western blot result was reported when there was discrete antibody-antigen binding was discrete antibody-antigen binding demonstrated on colorimetric detection. demonstrated on colorimetric detection. Positive antibody binding was compared Positive antibody binding was compared with the previously reported findings in with the previously reported findings in Sydenham's chorea (Church Sydenham's chorea (Church et al et al, 2002) . , 2002).
Statistics Statistics
All statistical tests were performed using All statistical tests were performed using the Statistical Package for the Social the Statistical Package for the Social Sciences version 12. The distribution of Sciences version 12. The distribution of the ELISA data was positively skewed, the ELISA data was positively skewed, therefore the planned comparisons between therefore the planned comparisons between the obsessive-compulsive disorder patient the obsessive-compulsive disorder patient cohort and the control cohorts were made cohort and the control cohorts were made with Mann-Whitney tests. Western with Mann-Whitney tests. Western blotting antibody positivity was compared blotting antibody positivity was compared using the chi-squared test. Clinical characusing the chi-squared test. Clinical characteristics of patients testing positive and teristics of patients testing positive and negative for anti-basal ganglia antibodies negative for anti-basal ganglia antibodies were compared using chi-squared tests. were compared using chi-squared tests.
RESULTS RESULTS
A summary of results is presented in A summary of results is presented in Table 2 . The mean anti-basal ganglia Table 2 . The mean anti-basal ganglia 31 5 31 5 antibody ELISA absorbance in the obsesantibody ELISA absorbance in the obsessive-compulsive disorder cohort was elesive-compulsive disorder cohort was elevated compared with the control groups vated compared with the control groups ( (P P5 50.005 in all comparisons). Likewise, 0.005 in all comparisons). Likewise, the presence of anti-basal ganglia antithe presence of anti-basal ganglia antibodies on western immunoblotting was bodies on western immunoblotting was significantly more common in the patient significantly more common in the patient cohort compared with all controls cohort compared with all controls ( (P P5 50.001 in all comparisons). Almost 0.001 in all comparisons). Almost two-thirds (64%) of the patient cohort with two-thirds (64%) of the patient cohort with positive findings on western blotting had an positive findings on western blotting had an ELISA level above 0.33 -the previously ELISA level above 0.33 -the previously proposed cut-off level (Church proposed cut-off level (Church et al et al, , 2002 ) -compared with 7% of the patient 2002) -compared with 7% of the patient group with negative western blotting. In group with negative western blotting. In the patient cohort, rather than polyspecific the patient cohort, rather than polyspecific binding using western blotting, there was binding using western blotting, there was antibody binding to discrete basal ganglia antibody binding to discrete basal ganglia antigens of molecular weight 40 ( antigens of molecular weight 40 (n n¼12), 12), 45 ( 45 (n n¼9) and 60 ( 9) and 60 (n n¼9). An example of a 9). An example of a patient and a control western blot is prepatient and a control western blot is presented in Fig. 1 . Fourteen of the 21 sented in Fig. 1 . Fourteen of the 21 samples testing positive for anti-basal samples testing positive for anti-basal ganglia antibodies had binding to one of ganglia antibodies had binding to one of these basal ganglia antigens, whereas the these basal ganglia antigens, whereas the other seven had binding to two or three of other seven had binding to two or three of these autoantigens. These antibody-antigen these autoantigens. These antibody-antigen binding patterns are similar to those prebinding patterns are similar to those previously reported in Sydenham's chorea viously reported in Sydenham's chorea (Church (Church et al et al, 2002) . There was other , 2002). There was other binding in the patient cohort samples to binding in the patient cohort samples to antigens of unclear significance: 30 kDa, antigens of unclear significance: 30 kDa, 35 kDa, 42 kDa and 67 kDa (all 35 kDa, 42 kDa and 67 kDa (all n n¼1), and 1), and 95 kDa and 98 kDa ( 95 kDa and 98 kDa (n n¼2). The clinical 2). The clinical characteristics characteristics of the patients who tested of the patients who tested positive for antipositive for anti-basal ganglia antibodies basal ganglia antibodies were compared with those who were were compared with those who were negative for these negative for these antibodies (see Table 1 ).
antibodies (see Table 1 ). The antibodyThe antibody-positive patients were more positive patients were more likely to have comorbid Tourette syndrome likely to have comorbid Tourette syndrome and raised anti-streptolysin O titres. The and raised anti-streptolysin O titres. The antibody-negative patients had a higher antibody-negative patients had a higher mean CY-BOCS score and hoarding/saving mean CY-BOCS score and hoarding/saving obsessions. There was no other statistically obsessions. There was no other statistically significant difference. significant difference.
DISCUSSION DISCUSSION
Neurobiology of obsessiveNeurobiology of obsessiveĉ ompulsive disorder compulsive disorder
Obsessive-compulsive disorder is characObsessive-compulsive disorder is characterised by intrusive, repetitive and distresterised by intrusive, repetitive and distressing thoughts or images (obsessions), and sing thoughts or images (obsessions), and repetitive or ritualistic actions (compulrepetitive or ritualistic actions (compulsions) (Stein, 2002) . Over the past few sions) (Stein, 2002) . Over the past few decades, convergent evidence from decades, convergent evidence from genetics, neuroimaging and pharmacology genetics, neuroimaging and pharmacology points towards a neuropsychiatric basis points towards a neuropsychiatric basis for this disorder, involving specific brain for this disorder, involving specific brain regions -particularly the orbitofrontal regions -particularly the orbitofrontal cortex and basal ganglia. The association cortex and basal ganglia. The association of obsessive-compulsive disorder with of obsessive-compulsive disorder with extrapyramidal movement disorders such extrapyramidal movement disorders such as Tourette syndrome, Huntington's as Tourette syndrome, Huntington's disease, Parkinson's disease and Sydendisease, Parkinson's disease and Sydenham's chorea further strengthens the ham's chorea further strengthens the neuroanatomical association with the neuroanatomical association with the basal ganglia (Stein, 2002) . A genetic basal ganglia (Stein, 2002) . A genetic vulnerability seems important in disease vulnerability seems important in disease expression of obsessive-compulsive disexpression of obsessive-compulsive disorder, given the high incidence of the order, given the high incidence of the condition and of tic disorders in family condition and of tic disorders in family members (Pauls members (Pauls et al et al, 1995) . Although a , 1995). Although a number of genetic polymorphisms involved number of genetic polymorphisms involved in neurotransmission have been implicated in neurotransmission have been implicated in some study cohorts, there is no unifying in some study cohorts, there is no unifying genetic locus. It is therefore proposed that genetic locus. It is therefore proposed that disease expression is multifactorial, requirdisease expression is multifactorial, requiring both a genetic predisposition and an ing both a genetic predisposition and an environmental trigger. It is also possible environmental trigger. It is also possible that there are subgroups within 'idiopathic' that there are subgroups within 'idiopathic' disorder cohorts with differing neurological disorder cohorts with differing neurological or psychological factors resulting in the or psychological factors resulting in the syndrome termed 'obsessive-compulsive syndrome termed 'obsessive-compulsive disorder'. disorder'.
Obsessive^compulsive disorder Obsessive^compulsive disorder after infectious disease after infectious disease
Further evidence for specific brain mechaFurther evidence for specific brain mechanisms in obsessive-compulsive disorder is nisms in obsessive-compulsive disorder is the long-recognised association between the long-recognised association between this disorder and infection or immunethis disorder and infection or immunemediated central nervous system disease. mediated central nervous system disease. For example, obsessive-compulsive behavFor example, obsessive-compulsive behaviours were reported in patients with iours were reported in patients with encephalitis lethargica during the 1916-encephalitis lethargica during the 1916-1927 epidemic, although parkinsonism 1927 epidemic, although parkinsonism was the most striking clinical feature was the most striking clinical feature (Von Economo, 1931) . The pathological (Von Economo, 1931) . The pathological abnormalities of encephalitis lethargica abnormalities of encephalitis lethargica were inflammatory infiltrates that were were inflammatory infiltrates that were relatively localised to the basal ganglia, relatively localised to the basal ganglia, leading to early speculation that obsessiveleading to early speculation that obsessivecompulsive disorder could occur secondary compulsive disorder could occur secondary to basal ganglia dysfunction (Von Economo, to basal ganglia dysfunction (Von Economo, 1931) . 1931).
Another infection-mediated cause of Another infection-mediated cause of secondary obsessive-compulsive disorder secondary obsessive-compulsive disorder 31 6 31 6 , 2000) and are even more evident in chronic 2000) and are even more evident in chronic or relapsing disease (Asbahr or relapsing disease (Asbahr et al et al, 1999) . , 1999). Like encephalitis lethargica, Sydenham's Like encephalitis lethargica, Sydenham's chorea is characterised by an inflammatory chorea is characterised by an inflammatory infiltrate, predominantly of the basal ganinfiltrate, predominantly of the basal ganglia (Von Economo, 1931) . Furthermore, glia (Von Economo, 1931) . Furthermore, recent magnetic resonance volumetric recent magnetic resonance volumetric measurement of brain regions demonmeasurement of brain regions demonstrated specific volumetric enlargement of strated specific volumetric enlargement of the basal ganglia in patients with Sydenthe basal ganglia in patients with Sydenham's chorea, although conventional magham's chorea, although conventional magnetic resonance images are normal (Giedd netic resonance images are normal (Giedd et al et al, 1995) .
, 1995).
In the late 1980s an apparently new In the late 1980s an apparently new post-streptococcal neuropsychiatric phenopost-streptococcal neuropsychiatric phenotype was recognised: motor tics and/or type was recognised: motor tics and/or obsessive-compulsive disorder (Swedo obsessive-compulsive disorder (Swedo et et al al, , 1998) . The syndrome was named 1998). The syndrome was named 'paediatric autoimmune neuropsychiatric 'paediatric autoimmune neuropsychiatric disorders associated with streptococcal disorders associated with streptococcal infections' (PANDAS), and was characinfections' (PANDAS), and was characterised by an abrupt onset of symptoms terised by an abrupt onset of symptoms after streptococcal infection, with a relapafter streptococcal infection, with a relapsing course associated with further infecsing course associated with further infections (Swedo tions (Swedo et al et al, 1998) . The recognition , 1998). The recognition of the PANDAS phenotype has led to of the PANDAS phenotype has led to speculation that post-streptococcal autospeculation that post-streptococcal autoimmunity might play a contributory part immunity might play a contributory part in a subgroup of 'idiopathic' tic disorders in a subgroup of 'idiopathic' tic disorders and obsessive-compulsive disorder. The and obsessive-compulsive disorder. The PANDAS concept and the role of auto-PANDAS concept and the role of autoimmunity in movement and psychiatric disimmunity in movement and psychiatric disorders (including Tourette syndrome) orders (including Tourette syndrome) remain controversial (Kurlan & Kaplan, remain controversial (Kurlan & Kaplan, 2004; Swedo 2004; Swedo et al et al, 2004) . , 2004).
Immunopathogenesis Immunopathogenesis of post-streptococcal brain disease of post-streptococcal brain disease
The favoured hypothesis regarding SydenThe favoured hypothesis regarding Sydenham's chorea and PANDAS pathogenesis ham's chorea and PANDAS pathogenesis states that an immune response raised states that an immune response raised against group A streptococcus cross-reacts against group A streptococcus cross-reacts with brain proteins owing to similarity in with brain proteins owing to similarity in the antigens, a concept called molecular the antigens, a concept called molecular mimicry. To date, most investigators have mimicry. To date, most investigators have focused on cross-reactive anti-neuronal focused on cross-reactive anti-neuronal antibodies as possible mediators of disease, antibodies as possible mediators of disease, although T cells may also be involved although T cells may also be involved (Husby (Husby et al et al, 1976; Kiessling , 1976; Kiessling et al et al, 1993; , 1993 . Limitations of western blotting and ELISA Limitations of western blotting and ELISA include the fact that both techniques alter include the fact that both techniques alter the conformation of the antigens and could the conformation of the antigens and could therefore affect antibody-antigen intertherefore affect antibody-antigen interaction. It would be preferable to use the action. It would be preferable to use the specific autoantigens in their physiological specific autoantigens in their physiological state. We are currently attempting to idenstate. We are currently attempting to identify these antigens. A separate group have tify these antigens. A separate group have found similar antibody findings (using found similar antibody findings (using immunofluorescence rather than western immunofluorescence rather than western immunoblotting) in individuals with motor immunoblotting) in individuals with motor tics in association with streptococcal infectics in association with streptococcal infection (Kiessling tion (Kiessling et al et al, 1993) . Pathogenic , 1993). Pathogenic effect of the antibodies in Sydenham's effect of the antibodies in Sydenham's chorea and PANDAS has been inferred by chorea and PANDAS has been inferred by the induction of disease in animals after the induction of disease in animals after PANDAS antibody (IgG) infusion (Hallett PANDAS antibody (IgG) infusion (Hallett et al et al, 2000) and symptom reduction , 2000) and symptom reduction after immunotherapies that remove IgG after immunotherapies that remove IgG (Perlmutter (Perlmutter et al et al, 1999 (Perlmutter et al et al, ). , 1999 ). An interesting recent development is the An interesting recent development is the demonstration of an antibody in people demonstration of an antibody in people with Sydenham's chorea that cross-reacts with Sydenham's chorea that cross-reacts with lysoganglioside (a neuronal cell surwith lysoganglioside (a neuronal cell surface molecule), resulting in altered neuronal face molecule), resulting in altered neuronal cell signalling (Kirvan cell signalling (Kirvan et al et al, 2003) . Identify-, 2003) . Identifying the 40 kDa, 45 kDa and 60 kDa autoing the 40 kDa, 45 kDa and 60 kDa autoantigens to see whether they are related to antigens to see whether they are related to lysoganglioside or represent other neuronal lysoganglioside or represent other neuronal markers will further our understanding of markers will further our understanding of the possible role of autoimmunity in movethe possible role of autoimmunity in movement and neuropsychiatric disorders. Role of post-streptococcal Role of post-streptococcal autoimmunity autoimmunity in obsessive^compulsive disorder in obsessive^compulsive disorder
We report here that 42% of patients with We report here that 42% of patients with obsessive-compulsive disorder (a consecuobsessive-compulsive disorder (a consecutive cohort of children and adolescents tive cohort of children and adolescents attending a specialist clinic) had circulating attending a specialist clinic) had circulating anti-basal antibodies. This is a highly anti-basal antibodies. This is a highly significant finding, as these antibodies are significant finding, as these antibodies are uncommonly found in the control groups uncommonly found in the control groups studied. In contrast, patients with the studied. In contrast, patients with the neurological disorder most robustly neurological disorder most robustly established as a post-streptococcal autoestablished as a post-streptococcal autoimmune disorder -Sydenham's choreaimmune disorder -Sydenham's choreaalmost always test positive for these antialmost always test positive for these antibodies using the same assays (Church bodies using the same assays (Church et et al al, 2002 ). These findings demonstrate that , 2002). These findings demonstrate that a subgroup of people with obsessivea subgroup of people with obsessivecompulsive disorder have antibody findings compulsive disorder have antibody findings similar to those seen in Sydenham's chorea, similar to those seen in Sydenham's chorea, suggesting that autoimmunity many have a suggesting that autoimmunity many have a role in the genesis and/or maintenance of role in the genesis and/or maintenance of the former disorder. Only a few other the former disorder. Only a few other studies have looked for anti-neuronal antistudies have looked for anti-neuronal antibodies in obsessivebodies in obsessive-compulsive disorder.
compulsive disorder. An indirect immunofluorescence method An indirect immunofluorescence method has been used in one small study of idiohas been used in one small study of idiopathic disease, and did demonstrate pathic disease, and did demonstrate increased brain antibody binding in the increased brain antibody binding in the group with the disorder (Kiessling group with the disorder (Kiessling et al et al, , 1994) . Two other studies found no 1994). Two other studies found no evidence of anti-neuronal autoantibodies evidence of anti-neuronal autoantibodies in people with the disorder (Murphy in people with the disorder (Murphy et al et al, , 1997; Hoekstra 1997; Hoekstra et al et al, 2003) . These discre-, 2003). These discrepancies in autoantibody findings in differpancies in autoantibody findings in different study cohorts could be due to different ent study cohorts could be due to different methods of antigen preparation (e.g. delipimethods of antigen preparation (e.g. delipidation, used in methods described here) dation, used in methods described here) or antibody detection (colorimetric or antibody detection (colorimetric v v. . enhanced chemiluminescence). The detecenhanced chemiluminescence). The detection method is particularly important, as tion method is particularly important, as sensitive techniques such as enhanced sensitive techniques such as enhanced chemiluminescence can pick up low titres chemiluminescence can pick up low titres of clinically insignificant antibodies in of clinically insignificant antibodies in healthy people. We use colorimetric detechealthy people. We use colorimetric detection, which we believe has reduced sensition, which we believe has reduced sensitivity but improved specificity. Although tivity but improved specificity. Although the presence of anti-neuronal antibodies is the presence of anti-neuronal antibodies is important in establishing a possible autoimportant in establishing a possible autoimmune aetiology in obsessive-compulsive immune aetiology in obsessive-compulsive disorder, it is also essential to demonstrate disorder, it is also essential to demonstrate that immune factors are pathogenic (rather that immune factors are pathogenic (rather than simply markers). It could be argued than simply markers). It could be argued that antibodies are produced as a result of that antibodies are produced as a result of neuronal damage or are a non-specific neuronal damage or are a non-specific response to recent streptococcal infection, response to recent streptococcal infection, therefore representing an epiphenomenon. therefore representing an epiphenomenon. However, the low prevalence of these antiHowever, the low prevalence of these antibodies in the neurological and streptococcal bodies in the neurological and streptococcal control groups makes this less likely. control groups makes this less likely.
The presence of anti-basal ganglia antiThe presence of anti-basal ganglia antibodies in some of the patients with bodies in some of the patients with obsessive-compulsive disorder raises the obsessive-compulsive disorder raises the possibility that these cases may differ from possibility that these cases may differ from those in which these antibodies are absent. those in which these antibodies are absent. We therefore compared the two groups We therefore compared the two groups to define any possible clinical differences. to define any possible clinical differences. In support of the role of streptococcal In support of the role of streptococcal infection, antibody-positive patients were infection, antibody-positive patients were more likely to have positive results on more likely to have positive results on streptococcal serological testing. However, streptococcal serological testing. However, titres of anti-streptolysin O were elevated titres of anti-streptolysin O were elevated in 31% of antibody-negative patients. in 31% of antibody-negative patients. Streptococcal infection is common in chilStreptococcal infection is common in children and therefore cannot be used as a dren and therefore cannot be used as a marker of post-streptococcal neuromarker of post-streptococcal neuropsychiatric disorder alone. The antibodypsychiatric disorder alone. The antibodypositive patients were also more likely positive patients were also more likely to have to have tics or Tourette syndrome, tics or Tourette syndrome, further supporting a link between further supporting a link between postpoststreptococcal autoimmunity and movement streptococcal autoimmunity and movement disorders. Other than these findings, there disorders. Other than these findings, there was no was no clear difference between the clear difference between the antibodyantibody-positive and antibody-negative positive and antibody-negative patients in terms of obsessive-compulsive patients in terms of obsessive-compulsive symptoms, comorbidity and family history. symptoms, comorbidity and family history. Importantly, the Importantly, the mean CY-BOCS score mean CY-BOCS score in the antibodyin the antibody-negative patients was negative patients was higher than in the antibody-positive higher than in the antibody-positive patients. This suggests that the absence of patients. This suggests that the absence of these antibodies was not due to remission these antibodies was not due to remission of disease: rather it suggests that there are of disease: rather it suggests that there are discrete subgroups of obsessive-compulsive discrete subgroups of obsessive-compulsive disorder with a differing pathogenesis. disorder with a differing pathogenesis.
The patients recruited to this study The patients recruited to this study attended a specialist clinic for children with attended a specialist clinic for children with obsessive-compulsive disorder, so it is conobsessive-compulsive disorder, so it is conceivable that our cohort contained children ceivable that our cohort contained children whose disorder was complicated, atypical whose disorder was complicated, atypical or therapy-resistant. Whether the autoor therapy-resistant. Whether the autoimmune subgroup in our study had disimmune subgroup in our study had disorders with a different natural history orders with a different natural history (perhaps more spontaneous remission, or (perhaps more spontaneous remission, or better long-term outcome) or differential better long-term outcome) or differential treatment responsiveness requires longitutreatment responsiveness requires longitudinal studies. However, all 50 patients dinal studies. However, all 50 patients had obsessive-compulsive disorder using had obsessive-compulsive disorder using internationally defined criteria (DSM-IV) internationally defined criteria (DSM-IV) and exhibited the range of obsessions, and exhibited the range of obsessions, compulsions (and comorbidities) previously compulsions (and comorbidities) previously described in the idiopathic condition. It described in the idiopathic condition. It would be important to compare these findwould be important to compare these findings with epidemiological samples of childings with epidemiological samples of childhood-and adult-onset disorder, and also hood-and adult-onset disorder, and also with other psychiatric disorders. Further with other psychiatric disorders. Further examination of this autoimmune subgroup examination of this autoimmune subgroup might provide insight into the neurobiology might provide insight into the neurobiology of obsessive-compulsive disorder and of obsessive-compulsive disorder and offer alternative therapies to patients with offer alternative therapies to patients with refractory illness in the future. refractory illness in the future.
Mimicry and autoantibody-mediated neuronal cell Mimicry and autoantibody-mediated neuronal cell signalling in Sydenham chorea. signalling in Sydenham chorea. Nature Medicine Nature Medicine, , 9 9, , 914^920. 914^920. Patients presenting with acute obsessive^compulsive disorder after pharyngeal infections should be investigated for streptococcal infection or carriage. infections should be investigated for streptococcal infection or carriage.
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The study did not demonstrate whether the anti-neuronal antibodies were
The study did not demonstrate whether the anti-neuronal antibodies were pathogenic or merely an epiphenomenon. pathogenic or merely an epiphenomenon. Our method used a brain homogenate rather than specific proteins. Identifying the autoantigens would help to determine whether the autoantibodies are specific. autoantigens would help to determine whether the autoantibodies are specific.
